InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
11
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Maggiore Christopher D., Director. Insider active across 1 company, notably Zivo Bioscience, Inc.. In total, 15 filings have been logged. Split: 11 buys · 1 sell. Total volume traded: €1.5m. Activity tracked since 2 June 2021. The latest transaction was filed on 8 April 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
20 shares@ US$16.250.0% of flowCommon StockSEC:0001654954-25-004085:0
1,300 shares0Common StockSEC:0001654954-25-000105:0
31,336 shares@ US$8.3416.2% of flowCommon StockSEC:0001654954-24-011071:0
Ideal exit: 19 May 2025 (T+270)
2,080 shares@ US$8.051.1% of flowCommon StockSEC:0001654954-24-009647:0
Ideal exit: 22 Apr 2025 (T+270)
6,273 shares0Common StockSEC:0001654954-24-007745:0
36,630 sharesCommon StockSEC:0001654954-24-007464:0
157,692 shares@ US$1.3012.7% of flowCommon StockSEC:0001654954-24-000086:0
Ideal exit: 24 Sept 2024 (T+270)
45,000 shares@ US$1.002.9% of flowCommon StockSEC:0001654954-23-015555:0
Ideal exit: 8 Sept 2024 (T+270)
5,200 shares@ US$3.52811.3% of flowCommon StockSEC:0001654954-23-001647:0
Ideal exit: 11 Jun 2023 (T+270)
5,200 shares@ US$3.52811.3% of flowCommon StockSEC:0001654954-22-012673:0
Ideal exit: 11 Jun 2023 (T+270)
28,363 shares@ US$3.55029.4% of flowCommon StockSEC:0001654954-22-001719:0
Ideal exit: 6 Nov 2022 (T+270)
7,560 shares@ US$2.63971.9% of flowCommon StockSEC:0001654954-22-000532:0
Ideal exit: 8 Oct 2022 (T+270)
7,560 shares@ US$2.63974.1% of flowCommon StockSEC:0001654954-22-000532
Ideal exit: 8 Oct 2022 (T+270)
100,000 shares@ US$4.9943.4% of flowCommon StockSEC:0001078782-21-000534:0
Ideal exit: 27 Feb 2022 (T+270)
100,000 shares@ US$4.9928.1% of flowCommon StockSEC:0001078782-21-000534
Ideal exit: 27 Feb 2022 (T+270)
15 of 15 declarations
About Maggiore Christopher D.
Christopher D. Maggiore is a Director at Zivo Bioscience, Inc. In this role, he participates in the governance of the company and strategic decision-making. Maggiore brings his expertise to support Zivo's mission.
